EBV vax tipped to prevent 200,000 cancer cases; Portuguese regulators suspend use of GSK vaccine;

> Cancer Research UK researchers think a vaccine for the Epstein-Barr virus could prevent up to 200,000 cases of cancer a year. Post

> Portuguese regulators have suspended use of a GlaxoSmithKline ($GSK) vaccine following adverse events. Article

> Pfizer ($PFE) has shown off the Russian production plant that positions it to win government Prevnar contracts. Feature

> A pilot study suggests Merck's ($MRK) shingles vaccine is safe for people with mild lupus. Research

> Sanofi ($SNY) expects Phase III data on its dengue vaccine by late September. News

> Valneva is continuing a Phase II/III of its Pseudomonas aeruginosa vaccine following an interim review. Release

> Australian researchers have talked up their preclinical DNA vaccines against HIV and hepatitis C. Article

> Academics in Texas are working on a vaccine against Escherichia coli but warn it is years away from Phase I. Piece

> CAP-CMV has raised $2.3 million for development of its human cytomegalovirus vaccine candidate. Item

> Unicef and WHO have donated cold chain equipment to areas of the Philippines affected by Typhoon Yolanda. News